Clinical Trials Directory

Trials / Completed

CompletedNCT02538692

Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome

Traditional Chinese Medicine Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome: a Randomized Placebo-controlled Trial and a Mechanistic Study

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Chengdu University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the efficacy and safety of a traditional Chinese medication Tong-Xie-Yao-Fang for patients with diarrhea-predominant irritable bowel Syndrome (IBS-D).

Detailed description

Participants: The sample size of this trial is 118, to test an odds ratio of 3.5 at a significance of 0.05 and power of 0.8. Intervention: Tong-Xie-Yao-Fang versus placebo Data collection: Standard operation procedure will be developed for how to interviewing the participants, how to use the IBS diary, how to enter the data into the electronic case report forms.

Conditions

Interventions

TypeNameDescription
DRUGTong-Xie-Yao-FangTong-Xie-Yao-Fang is a traditional Chinese formula. It is used for diarrhea management.
DRUGPlaceboThe placebo is the same as Tong-Xie-Yao-Fang in appearance.

Timeline

Start date
2015-12-01
Primary completion
2017-01-01
Completion
2017-03-01
First posted
2015-09-02
Last updated
2017-04-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02538692. Inclusion in this directory is not an endorsement.